Neuramis Deep + Lidocaine

NEURAMIS DEEP + LIDOCAINE

For clinics comparing closely related products, NEURAMIS DEEP + LIDOCAINE stands out through the connection between hyaluronic acid and lidocaine and deeper-fold correction, facial contour definition, and skin hydration. Its balanced deep-correction profile is most relevant when the treatment plan involves forehead lines, lips and perioral area, and cheeks and midface.

Where This Product Fits

A closer look at NEURAMIS DEEP + LIDOCAINE shows a product built around practical choices: what it contains, the type of correction it supports and how it differs from adjacent variants.

• Formulation focus: cross-linked hyaluronic acid and lidocaine
• Main professional objectives: deeper-fold correction, facial contour definition, skin hydration, and elasticity support
• Most relevant treatment areas: forehead lines, lips and perioral area, cheeks and midface, chin, and nasolabial folds
• Presentation details: 20mg/ml and 20 mg/ml

Together, these details give NEURAMIS DEEP + LIDOCAINE a specific place in the catalogue and make comparison with neighbouring versions more useful.

1. Filler and Gel Profile

NEURAMIS DEEP + LIDOCAINE is positioned as a balanced-to-structured profile for deeper folds, contour definition and moderate volume correction. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. How the Gel Supports Correction

NEURAMIS DEEP + LIDOCAINE is designed to provide physical support within professionally selected tissue planes. Its practical behaviour is linked to the gel profile: softer variants favour integration and refinement, while more structured variants are selected when projection, contour definition or volume replacement is the priority. This named variant balances correction and support according to its product profile.

3. Main Correction Goals

• Facial contour refinement
• Volume restoration
• Structural projection
• Deep-fold correction

4. Facial Areas Suited to This Profile

NEURAMIS DEEP + LIDOCAINE is commonly associated with:

• Jawline and masseter area
• Chin
• Lips and perioral area
• Cheeks and midface
• Nasolabial folds
• Marionette lines

Final placement and technique for NEURAMIS DEEP + LIDOCAINE follow the current product instructions and individual assessment.

5. Formulation and Syringe Specifications

For NEURAMIS DEEP + LIDOCAINE, the documented formulation includes Cross-linked hyaluronic acid, Hyaluronic acid, Lidocaine hydrochloride, and Sodium chloride. The composition is attached to this exact strength and presentation.

• Product: NEURAMIS DEEP + LIDOCAINE
• Product type: Professional injectable dermal filler
• NEURAMIS DEEP + LIDOCAINE: Variant profile: A balanced-to-structured profile for deeper folds, contour definition and moderate volume correction
• Reported strength or volume: 3 mg/mL, 20mg/mL, 1ml, and 20 mg/mL
• NEURAMIS DEEP + LIDOCAINE: Document-supported formulation: Cross-linked hyaluronic acid, Hyaluronic acid, Lidocaine hydrochloride, and Sodium chloride
• Package details: 1 syringe, 1ml, 1.0mL, and 1 mL
• NEURAMIS DEEP + LIDOCAINE: Storage profile: do not freeze, protect from direct light, and room-temperature storage is mentioned

6. Expected Integration and Result Profile

For NEURAMIS DEEP + LIDOCAINE, for this formulation, the visible profile is linked to the selected correction goal. Integration, projection and contour support should be assessed according to the named gel variant, treatment plane, area and quantity used rather than applying one duration claim to the entire product family.

7. Package and Storage Information

For this presentation, the reported package presentation includes 1 syringe, 1ml, 1.0mL, and 1 mL. The available product information specifies do not freeze, protect from direct light, and room-temperature storage is mentioned. The sealed outer box and current instructions remain the controlling handling reference.

9. Frequently Asked Questions

What is NEURAMIS DEEP + LIDOCAINE?

For NEURAMIS DEEP + LIDOCAINE, this presentation is a professional injectable dermal filler positioned as a balanced-to-structured profile for deeper folds, contour definition and moderate volume correction. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of NEURAMIS DEEP + LIDOCAINE?

For NEURAMIS DEEP + LIDOCAINE, for this formulation, its product profile centres on facial contour refinement, volume restoration, structural projection, and deep-fold correction. The final treatment objective and technique are selected by a qualified professional.

What does NEURAMIS DEEP + LIDOCAINE contain?

For this presentation, the documented formulation includes Cross-linked hyaluronic acid, Hyaluronic acid, Lidocaine hydrochloride, and Sodium chloride.

Which areas are associated with NEURAMIS DEEP + LIDOCAINE?

For NEURAMIS DEEP + LIDOCAINE, the product information associates the named variant with jawline and masseter area, chin, lips and perioral area, cheeks and midface, nasolabial folds, and marionette lines. Suitability and placement depend on the exact product instructions and individual assessment.

How is NEURAMIS DEEP + LIDOCAINE supplied?

the named variant is described with 1 syringe, 1ml, 1.0mL, and 1 mL. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For NEURAMIS DEEP + LIDOCAINE, the product should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. the product is positioned as a balanced-to-structured profile for deeper folds, contour definition and moderate volume correction.

10. Professional Use

Manufacturer-Confirmed Details

For the product, medytox identifies Neuramis as its hyaluronic-acid tissue-recovery biomaterial range and classifies it as a single-use sterile medical device. The manufacturer lists a 1.0ml packaging unit and storage at 2–25°C, protected from freezing, heat, direct sunlight and pressure. Confirm the exact variant and lidocaine status on the carton before publishing variant-specific details.